id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0813-0002,FDA,FDA-2012-N-0813,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Applications for Approval to Market New Drug; Revision of Postmarketing Reporting Requirements; Discontinuance",Notice,General Notice,2012-12-05T05:00:00Z,2012,12,2012-12-05T05:00:00Z,2013-01-05T04:59:59Z,2012-12-05T14:50:06Z,2012-29327,0,0,090000648117f7fe
FDA-2012-N-0813-0001,FDA,FDA-2012-N-0813,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Applications for FDA Approval to Market New Drug; Revision of Postmarketing Reporting Requirements-Discontinuance",Notice,General Notice,2012-08-01T04:00:00Z,2012,8,2012-08-01T04:00:00Z,2012-10-02T03:59:59Z,2012-08-01T16:36:49Z,2012-18771,0,0,09000064810bc3bb